Virobay, Inc. IPO Research Information

Virobay, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Virobay, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Virobay, Inc.	VBAY - NASDAQ	Withdrawn	$0.00	$0.00	3.8 million
Underwriter(s): Piper Jaffray, JMP Securities,
Co-Manager(s): Cantor Fitzgerald & Co., Summer Street Research Partners
Industry:
Filing(s): Filed 2014-09-10 Terms Added 2014-10-06

About Virobay, Inc. (adapted from Virobay, Inc. prospectus):
They are a clinical-stage biopharmaceutical company utilizing our cysteine cathepsin platform for the development and commercialization of novel drugs.

This description is adapted from Virobay, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Virobay, Inc. "VBAY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.